Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Acid Phosphatase, Prostate (ACPP) (Middle Region) Peptide

ACPP Reactivity: Human Host: Synthetic BP, WB
Catalog No. ABIN972840

Quick Overview for Acid Phosphatase, Prostate (ACPP) (Middle Region) Peptide (ABIN972840)

Target

ACPP (Acid Phosphatase, Prostate (ACPP))

Origin

Human

Source

  • 5
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    Middle Region

    Characteristics

    This is a synthetic peptide designed for use in combination with anti-ACPP antibody (Catalog #: ARP41913_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.

    Purification

    Purified
  • Application Notes

    Each Investigator should determine their own optimal working dilution for specific applications.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Concentration

    1 mg/mL

    Buffer

    Final peptide concentration is 1 mg/mL in PBS.

    Handling Advice

    Avoid repeated freeze-thaw cycles.

    Storage

    -20 °C

    Storage Comment

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target

    ACPP (Acid Phosphatase, Prostate (ACPP))

    Background

    This gene encodes an enzyme that catalyzes the conversion of orthophosphoric monoester to alcohol and orthophosphate. It is synthesized under androgen regulation and is secreted by the epithelial cells of the prostate gland. An alternatively spliced trans

    Alias Symbols: ACP-3, ACP3, PAP, 5'-NT

    Protein Interaction Partner: ACPP,ERBB2,SHBG,ACPP

    Protein Size: 386

    Molecular Weight

    41 kDa

    Gene ID

    55

    NCBI Accession

    NM_001099, NP_001090

    UniProt

    P15309
You are here:
Chat with us!